![](images/graphics/blank.gif)
Vemurafenib monotherapy
Xem 1-1 trên 1 kết quả Vemurafenib monotherapy
-
Rash is one of the most common severe adverse events associated with use of vemurafenib for the treatment of melanoma, either as monotherapy or in combination with cobimetinib. The study aimed to identify pre-treatment patient characteristics predictive of developing severe rash with vemurafenib therapy.
6p
vijakarta2711
09-06-2020
13
1
Download
CHỦ ĐỀ BẠN MUỐN TÌM
TOP DOWNLOAD
![](images/graphics/blank.gif)